S Picascia studies the impact of specific medical treatments, particularly immunotherapy, on the pancreas, which is a gland that helps with digestion and blood sugar regulation. One of their notable studies involved a case of a 71-year-old man who developed acute pancreatitis—an inflammation of the pancreas—after receiving immunotherapy for lung cancer. This inflammation can mimic cancer symptoms, leading to the need for careful diagnosis and treatment decisions. S Picascia's research helps healthcare providers recognize when these treatment-related complications occur, helping improve outcomes for patients undergoing similar therapies.
Key findings
Identified a case of drug-induced acute pancreatitis in a patient treated for lung cancer, demonstrating that treatment side effects can mimic cancer pathology.
Emphasized the importance of rapid diagnosis of drug-induced pancreatitis to improve treatment options and patient outcomes.
Highlighted how scans can initially mislead doctors into thinking a patient has pancreatic cancer when they actually have inflammation.
Frequently asked questions
Does Dr. Picascia study pancreatic diseases?
Yes, Dr. Picascia investigates conditions like acute pancreatitis, especially as they relate to cancer treatments like immunotherapy.
What treatments has Dr. Picascia researched?
Dr. Picascia's research includes the side effects of immunotherapy, particularly how it can lead to drug-induced complications in the pancreas.
Is Dr. Picascia's work relevant to patients undergoing cancer treatment?
Yes, their work is highly relevant as it helps identify potential side effects of cancer therapies, improving diagnosis and management for these patients.
Publications in plain English
REDAC: RNA-seq expression data analysis chatbot.
2026
Bioinformatics advances
De Filippis GM, Sahu P, Ambrosio P, Picascia S, Lo Monte M +9 more
Plain English This study introduced REDAC, a user-friendly online tool that helps researchers analyze RNA-seq expression data without needing deep bioinformatics expertise. REDAC allows users to ask questions in plain language, quickly run analyses, visualize results, and understand the biological significance of their findings. This is important because it makes complex data analysis more accessible and ensures consistent results, ultimately aiding in research efficiency.
Who this helps: Researchers and scientists who study gene expression.
T Cell-Mediated Immunity to Gliadin Is Elicited in the Gut Mucosa of Type 1 Diabetes Patients Only in Presence of Celiac Disease Comorbidity.
2025
Diabetes
Gianfrani C, Camarca A, Picascia S, Vitale S, Mottola I +6 more
Plain English This study looked at whether children with type 1 diabetes have certain immune cells in their gut that react to a protein called gliadin, especially if they also have celiac disease. The researchers found that these immune cells were absent in kids with type 1 diabetes who did not have celiac disease, but were present in those who did. This finding is important because it shows that the immune response to gliadin in the gut is linked only to those with celiac disease, and it suggests that gluten may not play a direct role in causing type 1 diabetes.
Who this helps: This helps children with type 1 diabetes and their doctors by clarifying the relationship between diabetes and gluten.
Detection of Gliadin-Activated CD4T Cells Is a New Assay to Reveal Pathogenic Lymphocytes in Celiac Disease.
2025
Journal of cellular and molecular medicine
Pisapia L, D'Ambrosio M, Mottola I, Picascia S, De Girolamo D +5 more
Plain English This study examined a new method for diagnosing celiac disease by detecting specific immune cells in the blood of patients. Researchers found that patients with untreated celiac disease had many more activated CD4T cells that react to gliadin (the gluten protein) compared to people on a gluten-free diet or healthy individuals, with counts significantly higher in untreated patients. This new test could make diagnosing celiac disease easier and less invasive, which is important for those who struggle with traditional testing methods.
Who this helps: This helps patients suspected of having celiac disease, especially those who might get inconclusive results from standard tests.
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant.
2023
Viruses
Del Mastro A, Picascia S, D'Apice L, Trovato M, Barba P +11 more
Plain English This study looked at how kidney transplant patients (who need immunosuppressive drugs) respond to a third dose of the Pfizer COVID-19 vaccine compared to healthy individuals. Researchers found that while both groups produced more antibodies against the original virus (Wuhan strain) after the booster shot, kidney transplant recipients had lower levels of antibodies, and neither group produced strong responses against the Omicron variant. This matters because it highlights the need for tailored vaccine strategies for kidney transplant patients, who are at higher risk for severe COVID-19 infection.
Who this helps: Patients who have had a kidney transplant.
Social integration as a determinant of inequalities in green space usage: Insights from a theoretical agent-based model.
2022
Health & place
Picascia S, Mitchell R
Plain English This study looked at why people with different backgrounds use urban green spaces (like parks) differently. Researchers created a model based on cities in Scotland and found that one main reason people decide to visit these spaces is how they perceive others who also use them. They discovered that when considering things like how easy it is to walk in a neighborhood and the quality of green spaces, there can be unexpected negative effects from efforts aimed at getting lower-income groups to visit more frequently.
Who this helps: This helps city planners and community organizations aiming to improve access to green spaces for everyone.
Analytical and functional approaches to assess the immunogenicity of gluten proteins.
2022
Frontiers in nutrition
Mamone G, Di Stasio L, Vitale S, Picascia S, Gianfrani C
Plain English This study looked at how gluten proteins, which can trigger celiac disease, affect the immune system. Researchers examined different types of gluten from grains and food products to see which gluten peptides cause immune reactions in people with celiac disease. They found effective methods to analyze these gluten proteins and their impact on immunity, especially using advanced techniques like mass spectrometry, while also experimenting with gut cells from patients to understand how these proteins stimulate immune responses.
Who this helps: This helps patients with celiac disease by providing insights for developing better treatments and gluten-free products.
Stocky/Packed Pancreas: A Case of Focal Drug-Induced Acute Pancreatitis Mimicking Cancer.
2022
Tomography (Ann Arbor, Mich.)
Di Serafino M, Ronza R, D'Auria D, Fiorentino R, Arundine D +9 more
Plain English This study examined a case where a 71-year-old man developed drug-induced acute pancreatitis (DIP) after receiving immunotherapy for lung cancer. Initially, scans showed signs that looked like pancreatic cancer, but later tests confirmed it was actually inflammation caused by the treatment, not a tumor. This finding is important because recognizing DIP quickly can lead to better treatment decisions and outcomes for patients.
Who this helps: This helps patients undergoing immunotherapy and their doctors.
HLA class II genes in precision-based care of childhood diseases: what we can learn from celiac disease.
2021
Pediatric research
Del Pozzo G, Farina F, Picascia S, Laezza M, Vitale S +1 more
Plain English This study looks at how certain genes related to the immune system can help in understanding and treating celiac disease (CeD) in children. Researchers found that the presence of specific genetic risk factors (HLA-DQ2.5 and HLA-DQ8) heavily influences the likelihood of developing CeD and the severity of the body's reaction to gluten. By using genetic testing, doctors could potentially diagnose CeD more accurately and provide tailored treatments early on, improving patient outcomes.
Who this helps: This helps patients with celiac disease and their doctors.
Triticum monococcum amylase trypsin inhibitors possess a reduced potential to elicit innate immune response in celiac patients compared to Triticum aestivum.
2021
Food research international (Ottawa, Ont.)
Iacomino G, Rotondi Aufiero V, Di Stasio L, Picascia S, Iannaccone N +5 more
Plain English This study looked at how certain proteins found in wheat affect the immune system of people with celiac disease. Researchers compared proteins from two ancient wheat varieties (Triticum monococcum) with those from common wheat (Triticum aestivum) and found that the proteins from the ancient wheat caused much less immune response in lab tests. Specifically, there was no significant immune reaction measured in the intestinal cells from celiac patients when exposed to the ancient wheat proteins, highlighting their potential safety for these patients.
Who this helps: This benefits celiac patients who need safe food options.
Situating agent-based modelling in population health research.
2021
Emerging themes in epidemiology
Silverman E, Gostoli U, Picascia S, Almagor J, McCann M +2 more
Plain English This study looked at how agent-based modeling (ABM) can improve our understanding of complex health issues influenced by social and environmental factors. The researchers found that ABM is particularly useful for tackling difficult problems in public health that traditional methods struggle to address, highlighting its potential to provide new insights and develop interventions. This is important because it can lead to better strategies for dealing with health issues that affect communities in severe ways.
Who this helps: This helps public health researchers and policymakers.
Intestinal Cellular Biomarkers of Mucosal Lesion Progression in Pediatric Celiac Disease.
2021
Pharmaceutics
Vitale S, Maglio M, Picascia S, Mottola I, Miele E +3 more
Plain English This study looked at how certain immune cells in the intestines change in children with celiac disease, focusing on the difference between those with overt celiac disease and those with potential celiac disease. Researchers found that the more harmful TCRγδ+ T cells increased while the protective IL4-producing T cells decreased as the disease progressed, indicating that these changes closely relate to the severity of intestinal damage. Identifying these cell types could help doctors find new ways to treat celiac disease and predict its progression.
Who this helps: This helps patients with celiac disease and their doctors.
Reinventing the nutraceutical value of gluten: The case of l-theanine-gluten as a potential alternative to the gluten exclusion diet in celiac disease.
2020
Food chemistry
Ribeiro M, Lopes S, Picascia S, Gianfrani C, Nunes FM
Plain English Researchers developed a new type of wheat flour that contains a substance called l-theanine, which may serve as a replacement for traditional gluten-free options in people with celiac disease. They found that this modified gluten could significantly lower the immune reaction that usually occurs with gluten in celiac patients' bodies, while still keeping some of the original benefits of gluten. This is important because it offers a potential new food choice for those who cannot eat gluten without sacrificing taste or texture.
Who this helps: This helps patients with celiac disease looking for better diet options.
In Celiac Disease Patients the In Vivo Challenge with the Diploid Triticum monococcum Elicits a Reduced Immune Response Compared to Hexaploid Wheat.
2020
Molecular nutrition & food research
Picascia S, Camarca A, Malamisura M, Mandile R, Galatola M +8 more
Plain English Researchers studied how two types of wheat—diploid Triticum monococcum (TM) and hexaploid Triticum aestivum (TA)—affect the immune system of patients with celiac disease (CD). They found that after eating bread made from TM, the patients showed no significant increase in immune responses, while those eating TA had a notable rise in immune cells related to gluten sensitivity (p<0.05). This matters because it highlights that TM may be less likely to trigger harmful immune reactions in people with CD than TA, potentially influencing dietary choices for those affected.
Who this helps: Patients with celiac disease.
Comparative Analysis ofDigestibility and Immunogenicity of Gliadin Proteins From Durum and Einkorn Wheat.
2020
Frontiers in nutrition
Di Stasio L, Picascia S, Auricchio R, Vitale S, Gazza L +3 more
Plain English This study examined how easily the proteins in two types of wheat—einkorn and common wheat—can be digested and how they affect people with celiac disease. It found that the proteins in einkorn wheat are digested more effectively, which reduces their potential to trigger an immune response in celiac patients, with a significant decrease in immune activation (<0.05). This matters because it suggests that einkorn wheat may be safer for people with celiac disease compared to regular wheat.
Who this helps: Celiac disease patients looking for safer dietary options.
Immunogenic Potential of Beer Types Brewed Withandspp. Malt Disclosed by Proteomics.
2020
Frontiers in nutrition
Spada V, Di Stasio L, Picascia S, Messina B, Gianfrani C +2 more
Plain English This study looked at the protein content of five different types of beer, including two made with einkorn wheat and one labeled as "gluten-free." It found that all beer types contained some proteins that could trigger an immune response in patients with celiac disease, but the levels were significantly reduced after digestion. Importantly, after digestion, the gluten levels in beers were below the threshold for being considered gluten-free, indicating that moderate consumption might be safe for celiac patients, but more research is needed to accurately measure gluten in all beers.
Who this helps: This benefits patients with celiac disease and their healthcare providers.
Differential expression of predisposing HLA-DQ2.5 alleles in DR5/DR7 celiac disease patients affects the pathological immune response to gluten.
2020
Scientific reports
Pisapia L, Picascia S, Farina F, Barba P, Gianfrani C +1 more
Plain English This study focused on how certain genetic markers in celiac disease patients influence their immune response to gluten. Researchers found that patients with the DR5/DR7 genetic profile produce a stronger immune reaction, with up to two times higher responses than those from healthy individuals, linked to higher levels of specific proteins associated with gluten recognition. This research is important because it helps to understand why some people with celiac disease react more strongly to gluten, paving the way for better diagnosis and tailored treatment strategies.
Who this helps: Patients with celiac disease and their doctors.
Exploring the effectiveness of a COVID-19 contact tracing app using an agent-based model.
2020
Scientific reports
Almagor J, Picascia S
Plain English This study looked at how effective a COVID-19 contact tracing app could be in stopping the spread of the virus in cities. The researchers created a computer model to simulate how the app might work alongside testing and found that when many people use the app and there is enough testing available, infection rates can drop significantly. For example, higher app usage led to fewer infections, but if testing isn't prioritized for people showing symptoms, it can overwhelm testing resources, making the app less effective.
Who this helps: This helps public health officials and governments improve their COVID-19 response strategies.
HLA-DQA1 and HLA-DQB1 Alleles, Conferring Susceptibility to Celiac Disease and Type 1 Diabetes, are More Expressed Than Non-Predisposing Alleles and are Coordinately Regulated.
2019
Cells
Farina F, Picascia S, Pisapia L, Barba P, Vitale S +4 more
Plain English This research studied how certain genetic markers (HLA-DQA1*05 and HLA-DQB1*02) are linked to celiac disease and type 1 diabetes by looking at their expression levels in patients. They found that these risk markers are more active than other, non-risk markers, leading to a stronger immune response against gluten, with a specific focus on the DQ2.5 molecule being better expressed in patients with both conditions. This matters because it helps us understand how genetic factors can influence autoimmune diseases and may lead to better prevention or treatment strategies.
Who this helps: This helps patients with celiac disease and type 1 diabetes.
E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance.
2019
Scientific reports
Cavaletti L, Taravella A, Carrano L, Carenzi G, Sigurtà A +8 more
Plain English Researchers studied a new enzyme called E40, which breaks down gluten proteins that cause Celiac Disease (CD). They found that E40 effectively reduces harmful gluten peptides, preventing an immune response in Celiac patients; specifically, it significantly lowered the release of inflammatory markers when tested with cells from these patients. This matters because it offers a potential way for people with gluten intolerance to manage their condition better, even if they accidentally ingest gluten.
Who this helps: This helps patients with Celiac Disease and gluten intolerance.
The intestinal expansion of TCRγδand disappearance of IL4T cells suggest their involvement in the evolution from potential to overt celiac disease.
2019
European journal of immunology
Vitale S, Santarlasci V, Camarca A, Picascia S, Pasquale AD +7 more
Plain English This study looked at children with celiac disease (CD) to understand why some have severe intestinal damage (overt CD) while others do not (potential CD). Researchers found that children with overt CD had significantly more TCRγδT cells in their intestines, while IL4T cells were almost absent in those with severe damage. These results indicate that different immune cell types play a role in the progression of celiac disease, which could help identify the disease's severity and guide treatment.
Who this helps: This helps doctors and researchers understand celiac disease better, leading to improved care for patients.
Expression level of risk genes of MHC class II is a susceptibility factor for autoimmunity: New insights.
2018
Journal of autoimmunity
Gianfrani C, Pisapia L, Picascia S, Strazzullo M, Del Pozzo G
Plain English This study looked at how the expression levels of certain genes related to MHC class II (a group of molecules important for immune response) influence the risk of developing autoimmune diseases. It found that higher levels of these MHC class II molecules can change how T cells (a type of immune cell) develop and function, which affects the body's ability to respond appropriately to its own tissues. This is important because understanding these mechanisms could help identify individuals at greater risk for autoimmune diseases and improve prevention strategies.
Who this helps: Patients at risk of autoimmune diseases.
In Situ Gluten-Chitosan Interlocked Self-Assembled Supramolecular Architecture Reduces T-Cell-Mediated Immune Response to Gluten in Celiac Disease.
2018
Molecular nutrition & food research
Ribeiro M, Picascia S, Rhazi L, Gianfrani C, Carrillo JM +3 more
Plain English This study looked at a new way to reduce the harmful immune response to gluten in people with celiac disease. Researchers found that mixing gluten with chitosan, a natural substance, created a new structure that made gluten harder to digest and less likely to trigger an immune reaction. Specifically, this new mix decreased tissue transglutaminase activity and the production of a harmful immune protein by 50%. This matters because it could lead to alternative treatments for celiac disease beyond the strict gluten-free diet that patients currently have to follow.
Who this helps: This helps patients with celiac disease.
Microwave-based treatments of wheat kernels do not abolish gluten epitopes implicated in celiac disease.
2017
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Gianfrani C, Mamone G, la Gatta B, Camarca A, Di Stasio L +6 more
Plain English Researchers studied whether microwaving wet wheat kernels would make them safe for people with celiac disease by reducing gluten. They found that while microwaving lowered gluten to less than 20 parts per million (ppm), it did not affect the harmful components of gluten that trigger celiac reactions, meaning that the process does not make the wheat safe for these patients as initially thought. This matters because it challenges previous claims that microwaving could make wheat gluten-free and highlights the need for better testing methods to ensure safety for those with celiac disease.
Who this helps: This helps patients with celiac disease and their healthcare providers.
Gliadin-Specific CD8T Cell Responses Restricted by HLA Class I A*0101 and B*0801 Molecules in Celiac Disease Patients.
2017
Journal of immunology (Baltimore, Md. : 1950)
Picascia S, Sidney J, Camarca A, Mazzarella G, Giardullo N +6 more
Plain English This study investigated how certain molecules in the immune system, known as HLA class I (specifically A*0101 and B*0801), affect the body’s response to gliadin proteins in patients with celiac disease. Researchers found that out of 97 tested gliadin peptides, 20 were able to bind to B*0801, and only 3 to A*0101, with 10 out of those 23 peptides triggering immune responses in celiac patients. This research is important because it shows how specific immune responses to gluten can be linked to certain genetic factors in celiac disease, which may lead to better understanding and management of the condition.
Who this helps: This helps patients with celiac disease and their doctors.
Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease.
2017
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Camarca A, Auricchio R, Picascia S, Fierro O, Maglio M +5 more
Plain English This study looked at children in Italy who are at high risk for celiac disease, a condition where eating gluten causes harm to the intestine. Researchers analyzed intestinal samples from 19 children and found that most with celiac disease showed an immune response to gliadin, a component of gluten. Even some children without celiac disease had a response when certain immune signals were blocked, suggesting early signs of gluten sensitivity might develop even before full-blown celiac disease. This is important because it helps us understand how gluten sensitivity can arise in children and could lead to earlier identification and management of the disease.
Who this helps: This helps patients and their families by providing insights for early detection of celiac disease.
Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge.
2017
Alimentary pharmacology & therapeutics
Mandile R, Picascia S, Parrella C, Camarca A, Gobbetti M +4 more
Plain English Researchers studied whether a special type of wheat flour, treated with bacteria and enzymes, could be safe for people with coeliac disease who usually cannot eat gluten. They found that this treated flour did not trigger an immune response in 20 patients after three days of eating it, while regular wheat did provoke a response. This matters because it shows that this processing method could potentially lead to new treatments for coeliac disease, allowing patients more dietary options.
Who this helps: Patients with coeliac disease.
HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
2016
Journal of autoimmunity
Pisapia L, Camarca A, Picascia S, Bassi V, Barba P +2 more
Plain English This research focused on the role of specific HLA genes, particularly the DQ2.5 molecules, in celiac disease, a disorder where the immune system reacts to gluten. The study found that in patients with celiac disease, the genes associated with DQ2.5 are expressed much more than other non-related genes, influencing how the immune system responds to gluten. This discovery helps clarify why these genes are linked to celiac disease, showing that the immune response's strength depends more on the amount of gluten present than on the specific gene makeup of the patients.
Who this helps: This benefits patients with celiac disease by improving understanding of their condition.
The cross-talk between enterocytes and intraepithelial lymphocytes.
2016
Molecular and cellular pediatrics
Vitale S, Picascia S, Gianfrani C
Plain English This research looked at how two types of cells in the gut—enterocytes and intraepithelial lymphocytes—work together to protect the intestine from harmful substances like germs and toxins. The study found that, in people with celiac disease, eating gluten can cause these cells to react poorly, leading to serious damage in the gut. This is important because understanding this process can help develop better treatments for intestinal issues, especially for those with celiac disease.
Who this helps: Patients with celiac disease and other intestinal immune disorders.
Human Peripheral Blood Mononuclear Cell Function and Dendritic Cell Differentiation Are Affected by Bisphenol-A Exposure.
2016
PloS one
Camarca A, Gianfrani C, Ariemma F, Cimmino I, Bruzzese D +6 more
Plain English This study looked at how exposure to Bisphenol-A (BPA), a chemical found in many plastics, affects immune cells in healthy adults. Researchers found that even low doses of BPA increased the growth of certain immune cells but decreased the production of important anti-inflammatory signals, specifically interleukin-10 and interleukin-13. These changes in immune cell behavior may contribute to a higher risk of inflammation and autoimmune diseases in people exposed to BPA.
Who this helps: This information is important for patients and health professionals concerned about the effects of environmental toxins on immune health.
Extensive in vitro gastrointestinal digestion markedly reduces the immune-toxicity of Triticum monococcum wheat: implication for celiac disease.
2015
Molecular nutrition & food research
Gianfrani C, Camarca A, Mazzarella G, Di Stasio L, Giardullo N +8 more
Plain English This study looked at how digestion affects the immune reactions of gliadin proteins from two types of wheat: an ancient variety called Triticum monococcum and a more common variety called Triticum aestivum. Researchers found that after thorough digestion, the gliadin from Triticum monococcum had significantly less immune activity, meaning it is less likely to trigger celiac disease symptoms. Specifically, the immune response to Triticum monococcum decreased drastically, while many gliadin proteins from the common wheat remained intact and could still provoke reactions in celiac patients.
Who this helps: This research benefits patients with celiac disease by identifying a potentially safer type of wheat for them.
Consistency in polyclonal T-cell responses to gluten between children and adults with celiac disease.
2015
Gastroenterology
Hardy MY, Girardin A, Pizzey C, Cameron DJ, Watson KA +7 more
Plain English This study looked at how T cells, which are part of the immune system, respond to gluten in children and adults with celiac disease. The researchers found that 73% of the children (30 out of 41) had T cells that reacted to the same gluten peptides as those from adults. This matters because it means that tests and treatments designed for adults with celiac disease could also work for children.
Who this helps: This helps patients, especially children with celiac disease, and their doctors.
Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications.
2015
Nutrients
Picascia S, Mandile R, Auricchio R, Troncone R, Gianfrani C
Plain English This study looked at how a small amount of gluten affects certain immune cells in people with celiac disease, a condition that makes it hard for them to digest gluten. The researchers found that after eating gluten for just three days, specific immune cells, called gliadin-specific T-cells, moved from the gut into the bloodstream, which is important for understanding how celiac disease works and improving diagnosis and treatment options. This matters because better diagnostic tools and therapies can lead to improved management of the disease.
Who this helps: Patients with celiac disease.
Cereal-based gluten-free food: how to reconcile nutritional and technological properties of wheat proteins with safety for celiac disease patients.
2014
Nutrients
Lamacchia C, Camarca A, Picascia S, Di Luccia A, Gianfrani C
Plain English This study looked at how to create gluten-free foods that are both nutritious and safe for people with Celiac Disease. Researchers found that while gluten helps give traditional baked goods their structure, making gluten-free options is challenging. They also examined the potential use of ancient or detoxified wheat species as alternatives for people with Celiac Disease.
Who this helps: This benefits individuals with Celiac Disease who need safe and tasty gluten-free food options.
The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors.
2012
The American journal of gastroenterology
Amitrano L, Guardascione MA, Manguso F, Bennato R, Bove A +7 more
Plain English This study looked at how well current treatments work for patients with liver cirrhosis who have serious bleeding from enlarged veins in the esophagus. Researchers examined 185 patients and found that 14.6% died within five days after treatment. They identified specific risk factors that indicate a higher chance of failure in treatment, including severe liver disease and certain blood counts.
Who this helps: This information benefits doctors treating patients with liver cirrhosis and helps them identify those at higher risk for poor outcomes.
In-hospital mortality in non-variceal upper gastrointestinal bleeding Forrest 1 patients.
2008
Scandinavian journal of gastroenterology
Manguso F, Riccio E, Bennato R, Picascia S, Martino R +3 more
Plain English This study looked at patients with serious upper gastrointestinal bleeding who were treated in the hospital. Out of 142 patients, 8 (5.6%) died during their stay, and 12% experienced rebleeding. The researchers found that having bleeding in multiple areas of the digestive tract and needing multiple blood transfusions were linked to a higher risk of death.
Who this helps: This information is valuable for doctors treating patients with severe gastrointestinal bleeding.
Endoscopic management of foreign bodies in the upper gastrointestinal tract: report on a series of 414 adult patients.
2001
Endoscopy
Mosca S, Manes G, Martino R, Amitrano L, Bottino V +12 more
Plain English This study looked at 414 adults who accidentally swallowed foreign objects, mostly food items or dental prosthetics, and how these cases were treated in a hospital setting. They found that endoscopy, a procedure where a flexible scope is used to remove the objects, successfully cleared 98.9% of the cases, with only three patients needing surgery. This is important because it shows that endoscopy is usually effective and safe for treating this common emergency, minimizing the need for surgical procedures.
Who this helps: Patients who accidentally swallow foreign objects and require urgent medical care.
Diffusion of knowledge about Helicobacter pylori as assessed in an open-access endoscopy system: a prospective observational study based on the Maastricht guidelines.
2001
Digestive diseases (Basel, Switzerland)
Manes G, Mosca S, Balzano A, Amitrano L, Bove A +6 more
Plain English This study looked at how well doctors followed guidelines for diagnosing and treating infections from a bacteria called Helicobacter pylori in patients with stomach issues. Researchers evaluated endoscopy practices in 706 patients in 1998 and 520 patients in 2001 and found that a large number of these procedures—about 56% in 1998 and 51% in 2001—were unnecessary, especially among younger patients who showed no serious symptoms. The findings highlight a significant improvement in the proper management of H. pylori-related conditions over time, but they also show that guidelines are still not being fully utilized, which means many unnecessary tests continue to be performed.
Who this helps: This helps patients who suffer from stomach issues by reducing unnecessary procedures and ensuring they receive appropriate treatment.